Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: J Immunother. 2014 Jan;37(1):8–15. doi: 10.1097/CJI.0000000000000010

FIGURE 1.

FIGURE 1.

Combining SS1P and ABT-737 induces dose-response decrease in cell proliferation. KLM-1 (A), BxPc-3 (B), and Panc 3.014 cell (C) proliferation data are presented after a 24-hour incubation with SS1P (10, 50, or 100 ng/mL), and/or ABT-737 (1, 5, or 10 μM). WST-8 data are normalized for staurosporine controls (1 μM) and untreated controls. Combining SS1P and ABT-737 had a significant dose-response effect on KLM-1 (A) and a moderate effect on BxPc-3 (B). In Panc 3.014 (C), no effect was observed.